163 related articles for article (PubMed ID: 19546456)
1. Initiation of insulin therapy in elderly patients taking oral antidiabetes drugs.
Pérez N; Moisan J; Sirois C; Poirier P; Grégoire JP
CMAJ; 2009 Jun; 180(13):1310-6. PubMed ID: 19546456
[TBL] [Abstract][Full Text] [Related]
2. Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: a 5-year survival analysis.
Gatwood JD; Chisholm-Burns M; Davis R; Thomas F; Potukuchi P; Hung A; Kovesdy CP
Diabet Med; 2018 Nov; 35(11):1571-1579. PubMed ID: 29978496
[TBL] [Abstract][Full Text] [Related]
3. Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study.
Grégoire JP; Sirois C; Blanc G; Poirier P; Moisan J
Value Health; 2010; 13(6):820-8. PubMed ID: 21054658
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemia-related emergency department visits and hypoglycemia-related hospitalizations among new users of antidiabetes treatments.
Moisan J; Breton MC; Villeneuve J; Grégoire JP
Can J Diabetes; 2013 Jun; 37(3):143-9. PubMed ID: 24070836
[TBL] [Abstract][Full Text] [Related]
5. Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiation.
Guénette L; Breton MC; Hamdi H; Grégoire JP; Moisan J
Can J Cardiol; 2013 Dec; 29(12):1593-8. PubMed ID: 24183301
[TBL] [Abstract][Full Text] [Related]
6. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
7. Treatment intensification using long-acting insulin -predictors of future basal insulin supported oral therapy in the DIVE registry.
Danne T; Bluhmki T; Seufert J; Kaltheuner M; Rathmann W; Beyersmann J; Bramlage P;
BMC Endocr Disord; 2015 Oct; 15():54. PubMed ID: 26446863
[TBL] [Abstract][Full Text] [Related]
8. Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes.
Levin PA; Zhou S; Gill J; Wei W
J Manag Care Spec Pharm; 2015 Dec; 21(12):1172-81. PubMed ID: 26679966
[TBL] [Abstract][Full Text] [Related]
9. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
Jacober SJ; Scism-Bacon JL; Zagar AJ
Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
[TBL] [Abstract][Full Text] [Related]
10. Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China.
Zhang L; Ji L; Guo L; Lu J; Tian H; Zhu D; Xing X; Weng JP; Jia W
Diabetes Technol Ther; 2015 Nov; 17(11):816-24. PubMed ID: 26448574
[TBL] [Abstract][Full Text] [Related]
11. Healthcare costs of the combination of metformin/dipeptidyl peptidase-4 inhibitors compared with metformin/other oral antidiabetes agents in patients with type 2 diabetes and metabolic syndrome.
Sicras-Mainar A; Navarro-Artieda R
Diabetes Technol Ther; 2014 Nov; 16(11):722-7. PubMed ID: 25089916
[TBL] [Abstract][Full Text] [Related]
12. [Insulin and oral antidiabetes drugs: how associate these treatments in ambulatory care?].
Abbet N; Gastaldi G; Philippe J
Rev Med Suisse; 2016 Jun; 12(521):1097-100. PubMed ID: 27487678
[TBL] [Abstract][Full Text] [Related]
13. Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later.
Thereaux J; Lesuffleur T; Czernichow S; Basdevant A; Msika S; Nocca D; Millat B; Fagot-Campagna A
JAMA Surg; 2018 Jun; 153(6):526-533. PubMed ID: 29450469
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study.
Kessing LV; Rytgaard HC; Ekstrøm CT; Knop FK; Berk M; Gerds TA
Diabetes Care; 2020 Dec; 43(12):3050-3060. PubMed ID: 32978179
[TBL] [Abstract][Full Text] [Related]
15. Delay of insulin initiation in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycemic agents (analysis of patient- and physician-related factors): A prospective observational DIPP-FACTOR study in Korea.
Kim SG; Kim NH; Ku BJ; Shon HS; Kim DM; Park TS; Kim YS; Kim IJ; Choi DS
J Diabetes Investig; 2017 May; 8(3):346-353. PubMed ID: 27712034
[TBL] [Abstract][Full Text] [Related]
16. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
[TBL] [Abstract][Full Text] [Related]
17. More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.
Dankner R; Roth J
Diabet Med; 2020 Feb; 37(2):194-202. PubMed ID: 31769894
[TBL] [Abstract][Full Text] [Related]
18. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents.
Mathew V; Frye RL; Lennon R; Barsness GW; Holmes DR
Am J Cardiol; 2004 Feb; 93(4):399-403. PubMed ID: 14969610
[TBL] [Abstract][Full Text] [Related]
19. Treatment intensification for patients with type 2 diabetes and poor glycaemic control.
Fu AZ; Sheehan JJ
Diabetes Obes Metab; 2016 Sep; 18(9):892-8. PubMed ID: 27160505
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China.
Zhang P; Chen M; Zhang H; Luo Y; Zhu D; Li X; Ji J; Wang D; Duolikun N; Ji L
BMC Endocr Disord; 2022 Jan; 22(1):26. PubMed ID: 35045841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
